欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0274/001
药品名称
Wilfactin
活性成分
Human normal immunoglobulin 1000.0 IU/10ml
剂型
Powder and solvent for solution for injection
上市许可持有人
LFB
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Netherlands (NL)
Luxembourg (LU)
Italy (IT)
Greece (GR)
Finland (FI)
许可日期
2005/07/01
最近更新日期
2024/11/20
药物ATC编码
B02 ANTIHEMORRHAGICS
B02BD Blood coagulation factors
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier [Article 8.3(i)]
TypeLevel4:
Biological: Blood Product
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
WILLFACT_common_PIL_20230208
Date of last change:2024/09/06
Final SPC
|
WILLFACT_common_SmPC_20230208
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase